Australia's most trusted
source of pharma news
Friday, 31 July 2026
Posted 31 July 2026 AM
A shortage of Ventolin Nebules is providing an opportunity to educate asthma patients about new care guidelines, the National Asthma Council (NAC) said.
GSK’s Ventolin Nebules (salbutamol sulfate) 5mg/2.5mL inhalation solution ampoules are unavailable until 17 August, while the 2.5mg/2.5mL ampoules have limited availability until 21 December, because of an “unexpected increase in demand due to other sponsors unable to supply”, the TGA said.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.